Artivion Inc

NYSE:AORT 4:00:00 PM EDT

25.92

+0.48 (+1.89%)

5:47:46 PM EDT: $27.21 +1.29 (+4.98%)

Market Cap (Intraday)	1.11B
Current PE	N/A
Forward PE	432
2yr Forward PE	123.43

See more stats

Estimates Current Quarter

Revenue	$94.71 Million
Adjusted EPS	-$0.06

See more estimates

10-Day MA	$25.84
50-Day MA	$25.56
200-Day MA	$22.53

See more pivots

Artivion Inc Stock, NYSE:AORT

1655 Roberts Boulevard NW, Kennesaw, Georgia 30144-3632

United States of America

Phone: +1.770.419.3355

Number of Employees: 1500

http://www.artivion.com

Description

Artivion, Inc. engages in the research and development of solutions which address cardiac and vascular surgeons' clinical challenges in treating patients with aortic diseases. Its products include aortic stents and stent grafts, prosthetic heart valves, cryopreserved cardiac and vascular allografts, and surgical sealants. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes aortic stents and stent grafts, surgical sealants, and On-X products. The Preservation Services segment offers cardiac and vascular tissue preservation services. The company was founded on January 19, 1984, and is headquartered in Kennesaw, GA.